Felodipine attenuates vascular inflammation in a fructose-induced rat model of metabolic syndrome via the inhibition of NF-κB activation

Acta Pharmacologica Sinica

Volumn 29, Issue 9, 2008, Pages 1051-1059

  Tan, Hong Wei ^a,b   Xing, Shan Shan ^a,b   Bi, Xiu Ping ^a,b   Li, Li ^a,b   Gong, Hui Ping ^a,b   Zhong, Ming ^a,b   Zhang, Yun ^a,b   Zhang, Wei ^a,b  

^a BEIJING HOSPITAL   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Adhesion molecule; Calcium channel blocker; Fructose fed rat; Metabolic syndrome

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CD68 ANTIGEN; CELL ADHESION MOLECULE; FELODIPINE; FRUCTOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; AORTA; ARTICLE; ATHEROSCLEROSIS; BODY WEIGHT; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; EXPERIMENTAL MODEL; GEL MOBILITY SHIFT ASSAY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INSULIN BLOOD LEVEL; MACROPHAGE MIGRATION; MACROPHAGE MIGRATION INHIBITION; MALE; METABOLIC SYNDROME X; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; RAT; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUGAR INTAKE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WISTAR RAT;

ANIMALS; BIOTRANSFORMATION; BLOOD GLUCOSE; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CELL ADHESION MOLECULES; CHOLESTEROL; FELODIPINE; FRUCTOSE; MALE; METABOLIC SYNDROME X; NF-KAPPA B; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VASCULITIS;

EID: 51349154249     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2008.00843.x     Document Type: Article

References (40)

1. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005 365 : 1415 28.
2. Zhong M, Tan HW, Gong HP, Wang SF, Zhang Y, Zhang W. Increased serum visfatin in patients with metabolic syndrome and carotid atherosclerosis. Clin Endocrinol (Oxf) 2008 Mar 20. [Epub ahead of print] doi: 10.1111/j.1365-2265. 2008.03248.x.
3. van Zwieten PA, Mancia G. Background and treatment of metabolic syndrome: a therapeutic challenge. Semin Cardiothorac Vasc Anesth 2006 10 : 206 14.
4. Garni AS, Witt BJ, Howard DE, Erwin PJ, Garni LA, Somers VK, et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 2007 49 : 403 14.
5. Kullo IJ, Cassidy AE, Peyser PA, Turner ST, Sheedy PF II, Bielak LF. Association between metabolic syndrome and subclinical coronary atherosclerosis in asymptomatic adults. Am J Cardiol 2004 94 : 1554 8.
6. Tzou WS, Douglas PS, Srinivasan SR, Bond MG, Tang R, Chen W, et al. Increased subclinical atherosclerosis in young adults with metabolic syndrome: the Bogalusa Heart Study. J Am Coll Cardiol 2005 46 : 457 63.
7. Delbosc S, Paizanis E, Magous R, Araiz C, Dimo T, Cristol JP, et al. Involvement of oxidative stress and NADPH oxidase activation in the development of cardiovascular complications in a model of insulin resistance, the fructose-fed rat. Atherosclerosis 2005 179 : 43 9.
8. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999 340 : 115 26.
9. Nageh MF, Sandberg ET, Marotti KR, Lin AH, Melchior EP, Bullard DC, et al. Deficiency of inflammatory cell adhesion molecules protects against atherosclerosis in mice. Arterioscler Thromb Vasc Biol 1997 17 : 1517 20.
10. Benitez MB, Cuniberti L, Fornari MC, Rosso LG, Berardi V, Elikir G, et al. Endothelial and leukocyte adhesion molecules in primary hypertriglyceridemia. Atherosclerosis 2008 197 : 679 87.
11. Haubner F, Lehle K, Munzel D, Schmid C, Birnbaum DE, Preuner JG. Hyperglycemia increases the levels of vascular cellular adhesion molecule-1 and monocyte-chemoattractant-protein-1 in the diabetic endothelial cell. Biochem Biophys Res Commun 2007 360 : 560 5.
12. Nissen SE, Tuzcu EM, Libby P, Thompson PD, Ghali M, Garza D, et al. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial. JAMA 2004 292 : 2217 25.
13. Pitt B, Byington RP, Furberg CD, Hunninghake DB, Mancini GB, Miller ME, et al. Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. PREVENT Investigators. Circulation 2000 102 : 1503 10.
14. Dai S, McNeill JH. Fructose-induced hypertension in rats is concen-tration-and duration-dependent. J Pharmacol Toxicol Methods 1995 33 : 101 7.
15. Zhao C, Wang P, Xiao X, Chao J, Chao L, Wang DW, et al. Gene therapy with human tissue kallikrein reduces hypertension and hy-perinsulinemia in fructose-induced hypertensive rats. Hypertension 2003 42 : 1026 33.
16. Tay A, Ozcelikay AT, Altan VM. Effects of L-arginine on blood pressure and metabolic changes in fructose-hypertensive rats. Am J Hy-pertens 2002 15 (1 Pt 1 72 7.
17. Miatello R, Vazquez M, Renna N, Cruzado M, Zumino AP, Risler N. Chronic administration of resveratrol prevents biochemical cardiovascular changes in fructose-fed rats. Am J Hypertens 2005 18 : 864 70.
18. Barros CM, Lessa RQ, Grechi MP, Mouço TL, Souza MG, Wiern-sperger N, et al. Substitution of drinking water by fructose solution induces hyperinsulinemia and hyperglycemia in hamsters. Clinics 2007 62 : 327 34.
19. Vaziri ND, Wang XQ, Ni ZN, Kivlighn S, Shahinfar S. Effects of aging and AT-1 receptor blockade on NO synthase expression and renal function in SHR. Biochim Biophys Acta 2002 1592 : 153 61.
20. Ortlepp JR, Breuer J, Eitner F, Kluge K, Kluge R, Floege J, et al. Inhibition of the renin-angiotensin system ameliorates genetically determined hyperinsulinemia. Eur J Pharmacol 2002 436 : 145 50.
21. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C (T)) Method. Methods 2001 25 : 402 8.
22. Brunner EJ, Hemingway H, Walker BR, Page M, Clarke P, Juneja M, et al. Adrenocortical, autonomic, and inflammatory causes of the metabolic syndrome: nested case-control study. Circulation 2002 106 : 2659 65.
23. Xu ZG, Lanting L, Vaziri ND, Li Z, Sepassi L, Rodriguez-Iturbe B, et al. Upregulation of angiotensin II type 1 receptor, inflammatory mediators, and enzymes of arachidonate metabolism in obese Zucker rat kidney: reversal by angiotensin II type 1 receptor blockade. Circulation 2005 111 : 1962 9.
24. Blankenberg S, Barbaux S, Tiret L. Adhesion molecules and atherosclerosis. Atherosclerosis 2003 170 : 191 203.
25. Moreno PR, Falk E, Palacios IF, Newell JB, Fuster V, Fallon JT. Mac-rophage infiltration in acute coronary syndromes. Implications for plaque rupture. Circulation 1994 90 : 775 8.
26. Iiyama K, Hajra L, Iiyama M, Li H, DiChiara M, Medoff BD, et al. Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation. Circ Res 1999 85 : 199 207.
27. Yoshii T, Iwai M, Li Z, Chen R, Ide A, Fukunaga S, et al. Regression of atherosclerosis by amlodipine via anti-inflammatory and anti-oxidative stress actions. Hypertens Res 2006 29 : 457 66.
28. Kataoka C, Egashira K, Ishibashi M, Inoue S, Ni W, Hiasa K, et al. Novel anti-inflammatory actions of amlodipine in a rat model of arteriosclerosis induced by long-term inhibition of nitric oxide synthesis. Am J Physiol Heart Circ Physiol 2004 286 : H768 74.
29. Yao R, Cheng X, Liao YH, Chen Y, Xie JJ, Yu X, et al. Molecular mechanisms of felodipine suppressing atherosclerosis in high-cholesterol-diet apolipoprotein E-knockout mice. J Cardiovasc Pharmacol 2008 51 : 188 95.
30. Yagi S, Goto S, Yamamoto T, Kurihara S, Katayama S. Effect of cilnidipine on insulin sensitivity in patients with essential hypertension. Hypertens Res 2003 26 : 383 7.
31. Ersoy C, Imamodlu S, Budak F, Tuncel E, Ertürk E, Oral B. Effect of amlodipine on insulin resistance & tumor necrosis factor-alpha levels in hypertensive obese type 2 diabetic patients. Indian J Med Res 2004 120 : 481 8.
32. Zhang WJ, Frei B. Alpha-lipoic acid inhibits TNF-alpha-induced NF-kappaB activation and adhesion molecule expression in human aortic endothelial cells. FASEB J 2001 15 : 2423 32.
33. Collins T, Cybulsky MI. NF-kappaB: pivotal mediator or innocent bystander in atherogenesis J Clin Invest 2001 107 : 255 64.
34. Arkan MC, Hevener AL, Greten FR, Maeda S, Li ZW, Long JM, et al. IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med 2005 11 : 191 8.
35. van den Berg R, Haenen GR, van den Berg H, Bast A. Transcription factor NF-kappaB as a potential biomarker for oxidative stress. Br J Nutr 2001 86 (Suppl 1 S121 7.
36. Takagawa Y, Berger ME, Hori MT, Tuck ML, Golub MS. Long-term fructose feeding impairs vascular relaxation in rat mesenteric arteries. Am J Hypertens 2001 14 (8 Pt 1 811 7.
37. International Diabetes Federation. The IDF consensus world-wide definition of the metabolic syndrome. Available from URL : http://www.idf.org/ webdata/docs/IDF Metabolic syndrome definition.
38. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Ger-mano G, et al. 2007 Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007 25 : 1105 87.
39. Athyros VG, Kakafika Al, Karagiannis A, Mikhailidis DP. Do we need to consider inflammatory markers when we treat atherosclerotic disease Atherosclerosis 2008 Mar 6. doi: 10.1016/j.atherosclersis.2008.02.026.
40. D'Angelo G, Elmarakby AA, Pollock DM, Stepp DW. Fructose feeding increases insulin resistance but not blood pressure in Sprague-Dawley rats. Hypertension 2005 46 : 806 11.